SCHEMBL16237441

SCHEMBL16237441

Nc1ccccc1Nc1ccc(F)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.56
MAPK13 O15264 3/20 0.56
MAPK12 P53778 3/20 0.56
MAPK11 Q15759 3/20 0.56
FADS1 O60427 1/20 0.55
MAPT P10636 6/20 0.53
KDM4E B2RXH2 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TP53 P04637 1/20 0.53
APP P05067 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
SNCA P37840 1/20 0.53
BLM P54132 1/20 0.53
HSD17B10 Q99714 1/20 0.53
ALDH1A1 P00352 5/20 0.52
GAA P10253 4/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
CYP1A2 P05177 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1170277 0.84 MAPT (0.58) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL255243 0.78 MAPT (0.70) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7199535 0.78 MAPK14 (0.74) MAPK14MAPK13MAPK12MAPK11FADS1
SCHEMBL4054374 0.77 MAPT (0.62) MAPK14MAPK13MAPK12MAPK11FADS1
SCHEMBL6656255 0.77 MAPK14 (0.70) MAPK14MAPK13MAPK12MAPK11FADS1
SCHEMBL7554636 0.77 SOS1 (0.60) MAPTAPPHPGDALOX15HSD17B10
SCHEMBL23609387 0.77 FFAR4 (0.45) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL29973284 0.77 FFAR4 (0.45) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7600214 0.76 MAPK14 (0.65) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL29580888 0.76 MAPT (0.56) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294212-B2 Inhibitors of the kynurenine pathway CURADEV PHARMA, PVT. LTD. (IN) 2019-05-21 US disclosed
EP-2970173-B1 INHIBITORS OF THE KYNURENINE PATHWAY CURADEV PHARMA PRIVATE LTD (IN) 2018-05-09 EP disclosed
US-20180030026-A1 INHIBITORS OF THE KYNURENINE PATHWAY CURADEV PHARMA PVT LTD 2018-02-01 US disclosed
US-9815811-B2 Inhibitors of the kynurenine pathway CURADEV PHARMA, PVT. LTD. (IN) 2017-11-14 US disclosed
US-20160046596-A1 INHIBITORS OF THE KYNURENINE PATHWAY CURADEV PHARMA PRIVATE LTD. (IN) 2016-02-18 US disclosed
EP-2970173-A1 INHIBITORS OF THE KYNURENINE PATHWAY Curadev Pharma Private Ltd. (IN) 2016-01-20 EP disclosed
WO-2014186035-A1 INHIBITORS OF THE KYNURENINE PATHWAY CURADEV PHARMA PRIVATE LTD. (IN) 2014-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294212-B2 Inhibitors of the kynurenine pathway IDO1, IDO2, KYNU MAPK14 1567/4885MAPK13 2085/4885MAPK12 2676/4885
US-20180030026-A1 INHIBITORS OF THE KYNURENINE PATHWAY IDO1, IDO2, KYNU MAPK14 1567/4885MAPK13 2085/4885MAPK12 2676/4885
US-20160046596-A1 INHIBITORS OF THE KYNURENINE PATHWAY IDO1, KYNU, IDO2 MAPK14 1308/4885MAPK13 1812/4885MAPK12 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.